Facebook
Twitter
LinkedIn
Forward
The Obesity Medicine Association (OMA) is a science leader regarding clinical obesity medicine. OMA has published several Clinical Practice Statements via its journal - Obesity Pillars.
|
This session will provide a comprehensive understanding of polycystic ovary syndrome (PCOS) focusing on its pathophysiology, diagnostic approaches in adolescence, and tailored treatment strategies.
|
Sarcopenia is becoming increasingly prevalent in the aging population with obesity, causing osteopenia, frailty, muscular weakness, and increased risk for falls.
|
Join us for an in-depth webinar designed for clinicians and scientists, exploring the intricate relationship between the gut microbiome and obesity.
|
This session will provide a practical guide to understanding and interpreting continuous glucose monitoring (CGM) data for healthcare providers managing patients with diabetes and obesity.
|
Discover how optimizing sleep can transform obesity medicine care and improve weight management outcomes.
|
This talk will explore the intricate relationship between the gut microbiome and obesity, shedding light on the critical role that microbes play in modulating body weight and metabolism.
|
Insulin resistance (IR) is a common biochemical abnormality in patients with excess adiposity, obesity, and its complications.
|
Obesity is a major risk factor for cardiovascular disease.
|
CME/CE Expiration Date: 4/26/27*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
|
Pages
- « first
- ‹ previous
- 1
- 2
- 3